PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2005/72 - ACTAVIS GROUP/ ALPHARMA
Acquiring
Actavis Group Hf
Description
is an undertaking under Icelandic law, operating as the parent company of a multinational group of companies that develop, manufacture and sell human generic pharmaceuticals on the international market, on the undertaking´s own behalf and that of third parties.
Acquired
Assets Alpharma Inc
Description
is a group of companies operating in the development, manufacture and marketing of human generics.
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Case description
Notified on 14 November 2005, this merger consists of the acquisition by Actavis Group Hf ("Actavis") of the entire share capital of certain Alpharma Inc ("Alpharma Genéricos") companies and assets involved in the production and sale of human generics.
Timeline
2005-12-23
Competition Authority approves Actavis acquisition of the totality of the registered capital of certain undertakings and assets in the production and sale of generic medicines for human use, under the ownership of Alpharma
Click here to see your activities